+1-786-628-7980
Sign Up/Sign In 
Gene Therapy Market Research Report Information By Product Type (Kymriah, Luxturna, Yescarta, Zolgensma, Zynteglo), By Indication (Oncology And Genetic Diseases), By End Users(Hospitals & Clinics, Specialty Treatment Centers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032
The Gene Therapy Market Size was valued at USD 0.95 billion in 2022 and is projected to grow from USD 1.13 billion in 2023 to USD 2.1 billion by 2032, exhibiting a CAGR of 6% during the forecast period (2023 – 2032).
Gene therapy is a revolutionary field in biotechnology that holds immense promise for treating a wide range of genetic and acquired diseases. It involves the introduction, deletion, or correction of genes within an individual’s cells to treat or prevent disease. The gene therapy market has witnessed significant growth and innovation in recent years, driven by advancements in genetic engineering technologies, increasing understanding of the human genome, and a growing demand for effective and personalized healthcare solutions.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/8399
Market Segmentation
The gene therapy market segmentation, based on product type, includes kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo and others.
The gene therapy market segmentation, based on indication, consists of oncology and genetic diseases.
By End Users, the market is segmented into Hospitals & Clinics, and Specialty Treatment Centers.
Competitive Analysis
The major market players are Amgen Inc. (US) Spark Therapeutics Inc. (US) Bristol-Myers Squibb Company (US) Novartis AG (Switzerland) Gilead Sciences Inc. (UUS Celgene Corporation (US) Thermo Fisher Scientific Inc. (US) CEVEC (Germany) uniQure N.V. (Netherlands) Orchard Therapeutics plc (UK).
Regional Analysis
In 2022, the North American gene therapy market was worth USD 1.13 billion, and it is projected to rise at a healthy CAGR over the course of the forecast period. There are several major market participants, a highly developed healthcare system, extensive reimbursement options, and a growing number of people living with and suffering from chronic illnesses. As a result, the market in North America is expected to grow over the projection period.
Browse In-depth Market Research Report (111 Pages) on Gene Therapy:
https://www.marketresearchfuture.com/reports/gene-therapy-market-8399
Europe’s second-largest market share in gene therapy can be attributed to the continent’s advanced healthcare infrastructure and government support for business expansion. More importantly, Germany was the largest market for gene therapy, while the UK was the fastest-growing market in Europe.
Discover More Research Reports on Healthcare Industry by Market Research Future:
From 2022 to 2030, the Asia-Pacific region is projected to have the highest compound annual growth rate (CAGR) in the gene therapy market. The existence of major firms, growth in government support, and ease of access to necessary materials all contribute to this. In addition, China’s gene therapy market was the largest overall and India’s was the fastest expanding in the Asia-Pacific.
Ulcerative Colitis Market Research Report Information By Type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Medication (5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.
Primary Osteoarthritis Market Research Report Information By Type (Knee, Hand, Neck, Hip, Wrist, Spinal, and Shoulder Osteoarthritis), Product Type, Drug Class (Combination Drug, LTA, ICS, SABA, LABA), Route of Administration, End User – Global Forecast till 2030
Cancer Supportive Care Market Research Report Information By Type (ESA (Erythropoiesis-Stimulating Agents), G-CSFs (Granulocyte Colony-Stimulating Factors), Antiemetics, Bisphosphonates, Opioids, NSAIDs (Non-Steroidal Auto Inflammatory Drugs), and Others), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Providers), and By Region (North America, Europe, Asia-Pacific
Stem Cell Therapy Market Research Report Information By Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood-Derived, IPSCs, PPSCs), By Type (Allogenic, Autologous), by Application (Cancer, Diabetes, MusculoskeletalDisorders, Cardiovascular, Gastrointestinal Diseases,Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Centers,Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
Oncology Information Systems Market Research Report Information By Product & Service Type (Software and Professional Services), By Application (Medical Oncology, Radiation Oncology and Surgical Oncology), By End User (Hospitals & Oncology Clinics, Government Institutes and Research Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
